↓ Skip to main content

Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery

Overview of attention for article published in Diabetes Technology & Therapeutics, May 2025
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery
Published in
Diabetes Technology & Therapeutics, May 2025
DOI 10.1089/dia.2024.0568
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 5 23%
Researcher 3 14%
Unspecified 2 9%
Professor 1 5%
Unknown 11 50%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 7 32%
Unspecified 2 9%
Biochemistry, Genetics and Molecular Biology 1 5%
Nursing and Health Professions 1 5%
Unknown 11 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 May 2025.
All research outputs
#26,628,283
of 32,151,140 outputs
Outputs from Diabetes Technology & Therapeutics
#1,772
of 1,964 outputs
Outputs of similar age
#251,977
of 344,975 outputs
Outputs of similar age from Diabetes Technology & Therapeutics
#10
of 15 outputs
Altmetric has tracked 32,151,140 research outputs across all sources so far. This one is in the 9th percentile – i.e., 9% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,964 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,975 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.